• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
N/A
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
No longer subject to file | 2011-05-13 | 0 | |
|
SCHACHLE JOSEPH K EVP, PULMONARY BUSINESS |
|
No longer subject to file | 2011-05-13 | 0 |
|
No longer subject to file | 2011-05-13 | 0 | |
|
No longer subject to file | 2011-05-13 | 0 | |
|
No longer subject to file | 2011-05-13 | 0 | |
|
STAAB THOMAS R II EVP, CFO & TREASURER |
|
No longer subject to file | 2011-05-13 | 0 |
|
ADAMS ADRIAN PRESIDENT AND CEO |
|
No longer subject to file | 2011-05-13 | 0 |
|
KOVEN ANDREW I EVP & CHIEF ADMIN & LEGAL OFC |
|
No longer subject to file | 2011-05-13 | 0 |
|
No longer subject to file | 2011-05-13 | 0 | |
|
BRAZZELL ROMULUS K EVP, MEDICAL & SCIENTIFIC |
|
No longer subject to file | 2011-05-13 | 0 |
|
No longer subject to file | 2011-05-13 | 0 | |
|
SPAGNARDI JOSEPH M SENIOR VP, GC & SECRETARY |
|
No longer subject to file | 2011-05-13 | 0 |
|
No longer subject to file | 2011-05-13 | 0 | |
|
No longer subject to file | 2011-05-13 | 0 | |
|
JOHNSON CHARLES A EVP OF R&D & CHIEF MED. OFCR. |
|
No longer subject to file | 2011-05-13 | 0 |
|
YERXA BENJAMIN R EVP & CHF, RESEARCH & DEVELOP |
|
0 | 2010-05-12 | 0 |
|
SHAFFER CHRISTY L PRESIDENT & CEO |
|
357,297 | 2009-12-07 | 0 |
|
KELLERMAN DONALD J SENIOR VP, DEVELOPMENT |
|
No longer subject to file | 2008-07-21 | 0 |
|
BENNETT MARY B EXEC. VP, OPERATIONS/COMM. |
|
10,000 | 2007-08-15 | 0 |
|
4,271,600 | 2007-08-01 | 0 | |
|
0 | 2007-07-20 | 0 | |
|
30,000 | 2007-06-08 | 0 | |
|
DEERFIELD SPECIAL SITUATIONS FUND, L.P. |
|
5,255,955 | 2007-04-30 | 0 |
|
1,286,000 | 2006-05-09 | 0 | |
|
EVANS RICHARD M VP, PHARMACEUTICAL DEVELOPMENT |
|
10,000 | 2006-01-19 | 0 |
|
PEA BARRY G EXEC. VP, CORP. DEV. & GC |
|
30,000 | 2006-01-19 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
